Wednesday, September 18, 2013 12:04:21 AM
no one knows how this will move going into the Oct decision date or afterwards. Always a chance for CRL, but less than less as each day passes.
I think if we move it all,it would be early Oct - 1 week prior... upward that is. I don't think we will see a significant downward draft into the Fed date, other than what we are seeing last and this week.
I think of this way. Instead of worrying about if we will pop 50 cents and lose the gain shortly afterwards, once the approval is IN, even if we don't get a pop or get a pop but lose it, one thing for sure going forward - The BASE of $4 will be a floor for this stock going forward w/ the approval. Sure, some will get disgruntled cuz we didn't get a big pop or as you say, got a pop but lose it quickly... but undeniable fact will be that ATRS business model would be confirmed, sales force will crank up and will start to deliver real revenue in house in 2014, albeit incrementally only.
So, at this point, I worry less about what the PPS will be before or after approval... just that we NEED a FDA approval, which will put a solid floor into PPS and over time, we will go higher..
FEATURED DaBaby and Stunna 4 Vegas's "NO DRIBBLE" Joins Music Licensing, Inc.'s Portfolio • Jun 7, 2024 10:15 AM
Mushrooms Inc. (OTC: MSRM) Announces Significant Share Buy Back by the Board Director and New Strategic Initiatives. • MSRM • Jun 5, 2024 1:32 PM
Hydromer Announces Launch of HydroThrombX Medical Device Coating Technology • HYDI • Jun 5, 2024 10:24 AM
Dr. Michael Dent Finances $1 Million to Drive HealthLynked's Healthcare Transformation • HLYK • Jun 5, 2024 8:00 AM
Avant Technologies Enters Binding LOI to Purchase Dozens of High-Performance, Immersible, AI-Powered Servers • AVAI • Jun 5, 2024 8:00 AM
IQST - iQSTEL Announces $290 Million 2024 Annual Revenue Forecast • IQST • Jun 4, 2024 1:43 PM